American Fusion Inc. (OTC: AMFN) announced it has received a Certificate for Industrial Radiation Machines from the Texas Department of State Health Services, authorizing research and development activities involving its Texatron Fusion Engine systems at Texas Tech University in Lubbock, Texas. The registration, effective through Feb. 28, 2034, permits the company to receive, possess, acquire, transfer and use registered industrial radiation machines for research and development under Texas radiation control regulations.
According to American Fusion, the authorization supports planned engineering, prototype testing and validation activities. The company stated that no other known material regulatory approvals are required to conduct planned testing of its 5 MW Texatron Fusion Engine at the approved research site. The registration marks a significant regulatory and operational milestone as American Fusion advances development of its Texatron platform. The authorization covers 12 registered research systems ranging from 500 kW to 1 GW and establishes the regulatory framework for continued engineering refinement, prototype testing, calibration, diagnostic evaluation and technical validation.
American Fusion said it plans to provide additional updates as future engineering, operational and regulatory milestones are achieved. The company is focused on the development and commercialization of next-generation fusion energy technologies through its Texatron Fusion Engine, a neutronic fusion platform designed for modular, infrastructure-grade deployment across industrial, commercial, and grid-constrained applications. The company's development strategy emphasizes system-level engineering, disciplined intellectual property protection, and scalable architectures intended to support long-term commercial operation, while maintaining a focus on capital discipline and transparent corporate governance.
For more information, visit the company's newsroom at http://ibn.fm/AMFN. The full press release is available at https://ibn.fm/Ary39.
